Atherothrombosis in clinical practice [electronic resource] /

Description based on print version record.

Includes bibliographical references and index.

Atherothrombosis / Andrew Yan and Basem El-Barouni -- Coronary artery disease / Flavio de Souza Brito, Renato D. Lopes, and Matthew T. Roe -- Valvular heart disease : ischemic syndromes due to atherothrombosis / Patrick Collier and Brian Griffin -- Cerebrovascular disease / Mark J. Alberts -- Atrial fibrillation / Yousif Ahmad and Gregory Y.H. Lip -- Peripheral artery disease / Amjad AlMahameed -- Lipid-modifying therapy / Chintan Patel, Roger S. Blumenthal, and Seth S. Martin -- Antithrombotic therapy / Amy Sarma and Michelle L. O'Donoghue -- Therapy for hypertension / Alexandros Briasoulis and George Bakris -- Therapy for type 2 diabetes / Kathleen Yip and Sangeeta Kashyap.

Cover; Contents; Preface; Contributors; 1. Atherothrombosis; 2. Coronary Artery Disease; 3. Valvular Heart Disease; 4. Cerebrovascular Disease: Ischemic Syndromes Due to Atherothrombosis; 5. Atrial Fibrillation; 6. Peripheral Artery Disease; 7. Lipid-Modifying Therapy; 8. Antithrombotic Therapy; 9. Treatment of Primary Hypertension; 10. Therapy for Type 2 Diabetes; Index; A; B; C; D; E; F; G; H; I; L; M; N; O; P; R; S; T; U; V; W

Atherothrombosis refers to the coupling of atherosclerosis and thrombosis, and it is the leading cause of the majority of preventable deaths in the modern world. The medical, economic, social, and societal consequences or atherothrombosis are enormous, which make it a dynamic area for development of new pharmacologic agents. Atherothrombosis in Clinical Practice focuses upon the many clinical manifestations of atherothrombosis and therapies that presently exist, with a focus on evolving therapeutic approaches. First, atherothrombosis is defined and the epidemiology is explored. Then, the speci.